Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV002310059 | SCV002604310 | likely pathogenic | Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset | 2021-11-19 | criteria provided, single submitter | clinical testing | NM_003494.3(DYSF):c.2778G>A(W926*) is expected to be pathogenic in the context of dysferlinopathy. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in DYSF, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |
Labcorp Genetics |
RCV003574904 | SCV004275645 | pathogenic | Qualitative or quantitative defects of dysferlin | 2024-09-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp926*) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with dysferlinopathy (PMID: 33610434). ClinVar contains an entry for this variant (Variation ID: 1724791). For these reasons, this variant has been classified as Pathogenic. |